Express Scripts Offers New Value-Based Program for Migraine
Recognizing a need to help patients and plans improve migraine management,
Moving to Preventive Care
"Right now, most patients take medication to make migraines go away. Our goal is to help frequent migraine sufferers prevent the migraine from coming on at all," said
Once on preventive therapy, these neuroscience specialist pharmacists will offer coaching for members to achieve optimal medication adherence, and to help members avoid migraine triggers. For members using newer calcitonin gene-related peptide (CGRP) inhibitors, our pharmacists will coach them on how to use these injectable medications and overcome barriers to achieving optimal results.
Affordable Access to Breakthrough Treatments
Clinical evidence for recently approved CGRP inhibitors has shown these therapies are effective in reducing the frequency of migraine headaches in patients who experience four or more migraines per month. While drug makers have priced CRGP inhibitors in line with independent value-based assessments from organizations such as the
Not all migraine suffers require CGRP-inhibitor therapy, but for those patients who meet the clinical guidelines for CGRP therapy, the Migraine Care Value program will prefer Aimovig™ (erenumab-aooe) and Emgality™ (galcanezumab-gnlm). As with any new-to-market medication, some patients will feel CGRP-inhibitors do not work for them. To help minimize plan sponsor exposure to the high cost of these therapies,
"CGRP inhibitors can be life-changing for people with frequent migraines which is why it's critical that these drugs be made affordable to both patients and plan sponsors," said Carter. "With our SafeGuardRx solutions, we have pioneered an evidence-based approach that will now help migraine sufferers receive the best medication and specialized care to enable them to lead full and productive lives while reducing costs and wasteful spending for our clients."
Our home base is
We believe healthcare can do more. We are Champions For BetterSM.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
View original content to download multimedia:http://www.prnewswire.com/news-releases/express-scripts-offers-new-value-based-program-for-migraine-300732702.html